Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
Chongqing Peg-Bio Biopharm Co., Ltd.
We are professional supplier of Intermediate of Semaglutide(P29).
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
8/10
1 Product Details
Chinese name:Insulin Icodec English name:Insulin Icodec
CAS:1188379-43-2 Brand:Peg-Bio
Place of Origin:Chongqing Storage Condition:-20°C
Purity:>98% Product Category:Insulin Icodec
Alias:Icoglucagon Origin/Manufacturer:Chongqing Paijin Biotechnology Co. ,Ltd
Character:Dry powder
Paijin Bio also adopts the recombinant expression technology of genetic engineering, using Brettanomyces cerevisiae as the recombinant expression host bacterium, and prepares Icodec API through the process steps of fermentation and cultivation, inducing the expression of precursors, solid-liquid separation, enzymolysis, fatty acid modification, purification, and drying, etc., which has the competitive advantages of high quality and low cost.
2 quality standard
Test Items | Standard designation | |
Nature | appearance | Should be a white or off-white powder |
Key Quality Indicators | molecular mass | 6380.38±1.0Da |
purity | Not less than 98% | |
polymer protein | < 1.0% | |
protein content | Should be 80%-100% | |
Routine Testing Program | dry weight loss | < 10.0% |
Host protein residues | <100ng/m | |
DNA residue | <10ng/7.7mg | |
microbial limit | <100cfu/g |
3 Advantages of cooperating with Peg-Bio Biopharm
(1) Paijin Biologicals has completed the development of kilograms of high-quality Icodec API
technology, which can meet the partner's needs for the development of small- and pilot-scale
compound formulations;
(2) Paigeon has completed the development of Icodec single preparation and IcoSema
compound preparation, and can provide one-stop technology development services, including
but not limited to: compound preparation prescription development, compound preparation
process development, compound preparation testing method development, compound
preparation in vivo efficacy evaluation;
(3) Paijin Icodec is in the process of declaring its DMF in the U.S.A., which is convenient for the
partner to declare its foreign registrations.